Patent Assignment
Reel/Frame 062319/0943
Patent Security Agreement
Recorded: 2023-01-07
Pages: 7
Assignor
CLOVIS ONCOLOGY, INC.
Executed: 2023-01-06
Assignee
TOP IV TALENTS, LLC, AS ADMINISTRATIVE AGENT
2100 MCKINNEY AVENUE, SUITE 1500, DALLAS, TEXAS, 75201
Covered Properties
(3)
High Dosage Strength Tablets of Rucaparib
High Dosage Strength Tablets of Rucaparib
Immunostimulatory Agents in Combination with Angiogenesis Inhibitors
Application:
17/231,307 →
Publication:
US 2021/0338656
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 19, 2015
From: ETTER, JEFFREY
To: CLOVIS ONCOLOGY, INC.
Reel/Frame 036362/0974 →
Assignment of Assignor's Interest
Mar 14, 2018
From: ETTER, JEFFREY
To: CLOVIS ONCOLOGY, INC.
Reel/Frame 045202/0602 →
Security Interest
May 6, 2019
From: CLOVIS ONCOLOGY, INC.
To: TOP IV SPV GP, LLC
Reel/Frame 049088/0950 →
Assignment of Assignor's Interest
May 26, 2023
From: CLOVIS ONCOLOGY, INC.
To: PHARMA& SCHWEIZ GMBH
Reel/Frame 063773/0353 →
Assignment of Assignor's Interest
Sep 23, 2024
From: ALKERMES PHARMA IRELAND LIMITED
To: MURAL ONCOLOGY, INC.
Reel/Frame 068663/0919 →
Assignment of Assignor's Interest
Sep 23, 2024
From: DUSEK, RACHEL; SIMMONS, ANDREW DAVID
To: CLOVIS ONCOLOGY, INC
Reel/Frame 068663/0579 →
Assignment of Assignor's Interest
Sep 23, 2024
From: LOPES, JARED; LOSEY, HEATHER C.; WINQUIST, RAYMOND J.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 068663/0459 →
Assignment of Assignor's Interest
Oct 11, 2024
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES PLC
Reel/Frame 068874/0671 →
Corrective Assignment to Correct the Assigor's Name from Alkermes Pharma Ireland Limited to Alkemers Plc as Noted on Assignment Document Previously Recorded on Reel 68663 Frame 919. Assignor(S) Hereby Confirms the Assignment.
Oct 11, 2024
From: ALKERMES PLC
To: MURAL ONCOLOGY, INC.
Reel/Frame 069432/0001 →